Official registry condition

Stroke peptide trials

6 selected ClinicalTrials.gov records carrying the official condition label Stroke. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

6 selected records.

Connected peptides

2 profiles.

Registry update years

2009–2019 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles2

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 56 selected PubMed records and 15 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Stroke unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00840671

PeptideScanner retained ClinicalTrials.gov record NCT00840671 at 2026-11-16T17:33:14.861Z. Its registry update date was 2010-12-28, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
December 28, 2010
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01388738

PeptideScanner retained ClinicalTrials.gov record NCT01388738 at 2026-11-16T17:33:14.861Z. Its registry update date was 2011-12-23, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
December 23, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02768571

PeptideScanner retained ClinicalTrials.gov record NCT02768571 at 2026-11-16T17:33:14.861Z. Its registry update date was 2019-09-20, and PeptideScanner's reviewed identity mapping was cerebrolysin.

PeptideScanner change date
November 16, 2026
Cited source date
September 20, 2019
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →